How much is the pharmaceutical industry worth in India?
Industry Scenario The pharmaceutical industry in India is currently valued at $41.7 bn. Generic drugs, with 71% market share, form the largest segment of the Pharmaceutical industry in India.
What is the revenue of pharmaceutical industry?
The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.27 trillion U.S. dollars in 2020.
How big is India’s pharmaceutical industry?
Market Size India’s domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to reach ~US$ 120-130 billion by 2030.
How much of the GDP is pharmaceutical industry?
The overall value added of the U.S. biopharmaceutical industry, or its contribution to U.S. GDP, is also substantial, with a total value added impact exceeding $625 billion, accounting for 3.2 percent of U.S. gross domestic product (GDP).
Is pharmaceutical industry profitable?
Sun pharma was the leading pharmaceutical company in India as of May 2021 with a net profit of almost 32 billion Indian rupees. Cipla and Dr Reddys labs came second and third respectively with net profits of around 24 and 21 billion rupees respectively during the stated time period.
Which is biggest pharma company in India?
Sun Pharma
By market capitalisation in Indian stock exchange
| Rank | Company | Market Capitalization August 2021 (INR crores) |
|---|---|---|
| 1 | Sun Pharma | 182,469 |
| 2 | Divi’s Laboratories | 128,794 |
| 2 | Dr. Reddy’s Laboratories | 75,113 |
| 4 | Cipla | 73,042 |
How big is the pharmaceutical industry 2020?
about 1.27 trillion U.S. dollars
As of end-2020, the total global pharmaceutical market was valued at about 1.27 trillion U.S. dollars. This is a significant increase from 2001 when the market was valued at just 390 billion U.S. dollars.
Who is owner of Sun Pharma?
Dilip Shanghvi
Dilip Shanghvi is the founder of Sun Pharmaceutical Industries Ltd. and has extensive industrial experience in the pharmaceutical industry. A first generation entrepreneur, Mr.
Is Pfizer an Indian company?
Pfizer Limited 2,000 crores, it is the fourth largest multinational pharmaceutical company in India. The Company has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13, Lyrica, Corex – DX, Dolonex, Enbrel, Becosules, Gelusil and Folvite among others.
How big is the pharmaceutical industry in India?
According to Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the total turnover of India’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion, while the domestic market was worth US$12.26 billion.
How big is the biotechnology industry in India?
The Indian biotechnology industry was valued at US$ 64 billion in 2019 and is expected to reach US$ 150 billion by 2025. India’s medical devices market stood at US$ 10.36 billion in FY20.
Are there any multinational pharma companies in India?
Thanks to the 1970 Patent Act, multinationals represent only 35% of the market, down from 70% thirty years ago. Most pharma companies operating in India, even the multinationals, employ Indians almost exclusively from the lowest ranks to high-level management.
What is the incentive program for pharmaceutical industry in India?
To foster an Atmanirbhar Bharat by enhancing the R&D, Make in India product development and high-value production capabilities, import substitution and domestic manufacture of active pharmaceutical ingredient (API) the government has introduced a US$2 billion incentive program which will run from 2021-22 to 2027-28.